Recent Quotes
My Watchlist
Indicators
Local Stocks
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY: JNJ )

179.04 +2.19 (+1.24%)
Streaming Delayed Price Updated: 2:31 PM EDT, May 16, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Johnson & Johnson

< Previous 1 2 3 4 5 6 7 8 9
...
31 32 Next >
Johnson & Johnson Stock: A Rare Bright Spot in the Market
JNJ stock is up on the year thanks in part to its steadily rising dividend, which investors covet during the current market volatility. 
Via InvestorPlace
Wall Street Extends Weekly Losing Streak Despite Upbeat Session
After a tumultuous week, Wall Street's midday rally held strong through the closing bell. 
Via Talk Markets
Biden Says US Ready To Share COVID-19 Vaccine Related Technology
 
Via Benzinga
White House Says Currently No Plans To Share COVID-19 Shots With North Korea Battling Outbreak
The Biden administration says it currently has no plans to share COVID-19 vaccines with North Korea, Reuters reported citing White House press secretary Jen Psaki. However, it supported providing aid... 
Via Benzinga
Read Why HC Wainwright Lowered Price Target On This Small Biotech Stock
U.S. marketing application filing for Cidara Therapeutics Inc's (NASDAQ: CDTX) rezafungin remains on track for mid-2022, setting up a potential early 2023 approval and launch. 
Via Benzinga
Almost 400M COVID-19 Vaccine Doses Lost Due To Emergent's Baltimore Plant Fiasco
 
Via Benzinga
Tuesday Talk: The Rough Ride Continues
At the moment there seems to be no respite on the ride down, markets opened the week on Monday, by closing markedly down again. Market futures are still up heading into the open. 
Via Talk Markets
Let Dividend Stocks Protect You From The Bear Market
The market has been brutal in 2022, especially over the past couple of months. 
Via Talk Markets
This Is What Whales Are Betting On Johnson & Johnson
A whale with a lot of money to spend has taken a noticeably bullish stance on Johnson & Johnson. Looking at options history for Johnson & Johnson (NYSE:JNJ) we detected 20 strange trades. 
Via Benzinga
4 Blue-Chip Stocks to Buy for May 2022
Apple, Alphabet, Johnson & Johnson and Procter & Gamble are our blue-chip stocks to buy this month as bulls looks for safe yet solid stocks. 
Via InvestorPlace
9 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Morning Brief: Top Financial Stories Dominating on Friday, May 6
Reuters IHG Hotels & Resorts On Way To Recovery As Travel Booms 
Via Benzinga
FDA Limits Use of Johnson & Johnson's COVID-19 Vaccine to Certain Individuals - All You Should Know
The FDA said it was limiting the use of Johnson & Johnson's (NYSE: 
Via Benzinga
Johnson & Johnson Whale Trades Spotted
A whale with a lot of money to spend has taken a noticeably bearish stance on Johnson & Johnson. Looking at options history for Johnson & Johnson (NYSE:JNJ) we detected 10 strange trades. 
Via Benzinga
US Study Shows Omicron As Severe As Previous COVID Variants: Reuters
 
Via Benzinga
What ETF Is Best? 7 Great Funds to Consider.
ETF investing is a great way to gain exposure to thematic stocks while limiting downside risk with diversification. 
Via InvestorPlace
3 Mighty Mutual Funds to Buy for Q2
Investors looking to profit from growth across industries should consider these three robust mutual funds to buy. 
Via InvestorPlace
Washington, Drug Distributors Reach $518M Settlement For Opioid Claims
 
Via Benzinga
It Pays to Be Greedy
Despite a tough start to 2022, intelligent investors will follow Warren Buffett’s advice and “be greedy when others are fearful” and stay in. 
Via InvestorPlace
Fourth COVID-19 Shot? See Why Medical Professionals Are Skeptical
Medical professionals are undecided on whether a fourth dose of the Covid-19 vaccine would benefit the wider population, as countries are beginning to offer the fourth dose to vulnerable groups. 
Via Benzinga
Emergent BioSolutions Suspends CDMO Guidance As It Awaits Clarity On COVID-19 Vaccine Requirements
 
Via Benzinga
How is it going with the Big Biopharma Earnings Week?
Abbott and JNJ kicked off healthcare earnings last week and the results were just OK. 
Via Talk Markets
Morning Brief: Top Financial Stories Dominating on Thursday, April 28
CNBC Ford Motor Slashes 580 Jobs, Mainly In Engineering Ford Motor Co (NYSE: F) is slashing 580 U.S. salaried employees and agency workers as part of its ongoing Ford+... 
Via Benzinga
Six US States Probing Mysterious Liver Inflammation In Kids: Bloomberg
At least six U.S. states are reporting confirmed or suspected cases of an unexplained, severe liver disorder in children. Health officials in New York state and Wisconsin said they’re investigating... 
Via Benzinga
7 Long-Term Stocks to Buy for a Robust Retirement
Consider these long-term stocks to buy, if you're looking to build a retirement portfolio that provides both income and capital growth. 
Via InvestorPlace
Morning Brief: Top Financial Stories Dominating on Wednesday, April 27
Reuters Kellogg Sues British Government Over New Sugar Rules Kellogg Co (NYSE: K) is suing the British government over new rules stopping the display of its breakfast cereals in... 
Via Benzinga
Johnson & Johnson Initiates Legal Action Against Entities Selling Fake HIV Medications
Johnson & Johnson (NYSE: JNJ) has filed the latest lawsuit to combat illicit sales of drugs in the U.S., alleging that several drug distributors and pharmacies are selling counterfeit versions of its... 
Via Benzinga
Check Out What Whales Are Doing With JNJ
Someone with a lot of money to spend has taken a bearish stance on Johnson & Johnson (NYSE:JNJ). And retail traders should know. We noticed this today when the big position showed up on publicly... 
Via Benzinga
3 Dividend Stocks for Value Investors Seeking Regular Income
The list includes high dividend paying stocks that are growing at a steady rate, suitable for income-seeking investors. 
Via InvestorPlace
San Francisco To Start Opioid Epidemic Trial Against Teva, Walgreen: Reuters
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
31 32 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.